Kimberly-Clark (NYSE:KMB) Releases Earnings Results, Beats Estimates By $0.14 EPS

Kimberly-Clark (NYSE:KMB) posted its quarterly earnings data on Tuesday. The company reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.69 by $0.14, Briefing.com reports. Kimberly-Clark had a return on equity of 223.55% and a net margin of 11.28%. The company had revenue of $4.95 billion during the quarter, compared to analysts’ expectations of $5.06 billion. During the same period in the prior year, the business earned $1.74 earnings per share. Kimberly-Clark’s revenue for the quarter was down 3.5% compared to the same quarter last year.

Kimberly-Clark Price Performance

NYSE:KMB traded up $0.12 on Thursday, reaching $137.01. The stock had a trading volume of 1,827,975 shares, compared to its average volume of 2,120,422. The company has a quick ratio of 0.58, a current ratio of 0.85 and a debt-to-equity ratio of 5.59. The company has a market capitalization of $46.13 billion, a P/E ratio of 25.19, a price-to-earnings-growth ratio of 2.98 and a beta of 0.39. Kimberly-Clark has a 1-year low of $116.63 and a 1-year high of $149.30. The stock has a fifty day moving average price of $143.18 and a 200-day moving average price of $138.66.

Kimberly-Clark Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 2nd. Investors of record on Friday, September 6th were issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.56%. The ex-dividend date was Friday, September 6th. Kimberly-Clark’s dividend payout ratio is currently 89.71%.

Insider Transactions at Kimberly-Clark

In other news, insider Gonzalo Uribe sold 1,780 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $140.84, for a total value of $250,695.20. Following the transaction, the insider now directly owns 7,377 shares of the company’s stock, valued at $1,038,976.68. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.62% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on KMB. Wells Fargo & Company reduced their price target on shares of Kimberly-Clark from $138.00 to $134.00 and set an “equal weight” rating for the company in a report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft lifted their target price on Kimberly-Clark from $146.00 to $147.00 and gave the stock a “hold” rating in a research report on Tuesday, October 8th. UBS Group cut their price target on Kimberly-Clark from $153.00 to $151.00 and set a “neutral” rating for the company in a report on Wednesday. Piper Sandler lifted their price objective on Kimberly-Clark from $167.00 to $174.00 and gave the stock an “overweight” rating in a report on Thursday, July 11th. Finally, JPMorgan Chase & Co. cut their target price on Kimberly-Clark from $142.00 to $140.00 and set an “underweight” rating for the company in a research note on Wednesday. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $149.93.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.